Crocs
CROX
115.20
-5.02
-4.18%
Crocs
US · CROX
#1991 by market cap
Listed 1970
115.20
-5.02
-4.18%
Live - 5344 symbols - heartbeat 107s ago
· 2026-10-08 07:08
Pre-market
114.20
-0.87%
After-hours
115.50
+0.26%
Overnight
115.18
-0.02%
- Market cap
- 5.52B
- P/E (TTM)i
- 10.22
- P/Bi
- 3.99
- EPSi
- -1.50
- Div yieldi
- 0.00%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on CROX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.04, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.50% YoY
Margins
- Gross margin
- 58.33%
- Operating margin
- 21.97%
- Net margin
- -2.01%
Key ratios & quality
- Enterprise valuei
- 6.71B
- Altman Z-Scorei
- 4.04
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.09B | 1.23B | 1.39B | 2.31B | 3.55B | 3.96B | 4.10B | 4.04B |
| Gross profit | 560.15M | 617.06M | 749.95M | 1.42B | 1.86B | 2.21B | 2.41B | 2.36B |
| Selling & admin expenses | 495.03M | 488.41M | 514.75M | 737.16M | 982.71M | 1.15B | 1.34B | 1.44B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 65.13M | 128.65M | 235.20M | 683.06M | 850.76M | 1.05B | 1.05B | 887.63M |
| Pretax profit | 65.16M | 119.32M | 206.98M | 663.85M | 718.51M | 876.27M | 910.59M | 72.98M |
| Tax | 14.72M | -175.00K | -105.88M | -61.85M | 178.35M | 83.71M | -39.49M | 154.18M |
| Net profit | 50.44M | 119.50M | 312.86M | 725.69M | 540.16M | 792.57M | 950.07M | -81.20M |
| Basic EPS | -1 | 2 | 5 | 12 | 9 | 13 | 16 | -2 |
| Diluted EPS | -1.01 | 1.66 | 4.56 | 11.39 | 8.71 | 12.79 | 15.88 | -1.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 937.33M | 1.15B | 996.30M | 957.64M | 921.46M | 1.18B |
| Gross profit | 541.55M | 708.84M | 583.01M | 523.66M | 522.95M | 700.71M |
| Selling & admin expenses | 318.58M | 398.24M | 375.35M | 343.42M | 322.10M | 415.03M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 222.97M | 310.60M | 207.66M | 146.40M | 200.84M | 285.68M |
| Pretax profit | 204.94M | -448.61M | 189.43M | 127.22M | 178.84M | 263.92M |
| Tax | 44.84M | 43.68M | 43.61M | 22.05M | 41.29M | 59.04M |
| Net profit | 160.10M | -492.28M | 145.82M | 105.17M | 137.56M | 204.89M |
| Basic EPS | 3 | -9 | 3 | 2 | 3 | 4 |
| Diluted EPS | 2.83 | -8.82 | 2.70 | 2.03 | 2.71 | 4.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 380.30M | 425.38M | 492.84M | 666.57M | 1.03B | 910.70M | 872.27M | 885.88M |
| Cash & ST investments | 123.37M | 108.25M | 135.80M | 213.20M | 191.63M | 149.29M | 180.49M | 130.35M |
| Inventory | 124.49M | 172.03M | 175.12M | 213.52M | 471.55M | 385.05M | 356.25M | 368.69M |
| Total assets | 468.90M | 738.80M | 1.12B | 1.55B | 4.50B | 4.64B | 4.81B | 4.17B |
| Total current liabilities | 184.49M | 257.22M | 291.58M | 388.24M | 641.27M | 698.30M | 740.21M | 700.13M |
| Short-term debt | -- | 48.59M | 47.06M | 42.93M | 81.82M | 85.60M | 68.55M | 85.77M |
| Long-term debt | 120.00M | 205.00M | 180.00M | 771.39M | 2.30B | 1.64B | 1.35B | 1.23B |
| Total liabilities | 318,593,000.00 | 606,897,000.00 | 828,090,000.00 | 1,530,986,000.00 | 3,683,866,000.00 | 3,189,911,000.00 | 2,976,421,000.00 | 2,881,467,000.00 |
| Total equity | 150.31M | 131.91M | 290.63M | 14.08M | 817.93M | 1.45B | 1.84B | 1.29B |
| Retained earnings | 121.22M | 240.49M | 553.35M | 1.28B | 1.82B | 2.61B | 3.56B | 3.48B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.07B | 1.10B | 971.19M | 885.88M | 1.07B | 1.08B |
| Cash & ST investments | 166.46M | 200.61M | 153.97M | 130.35M | 130.88M | 170.28M |
| Inventory | 391.30M | 405.14M | 397.07M | 368.69M | 397.56M | 389.21M |
| Total assets | 5.07B | 4.45B | 4.30B | 4.17B | 4.34B | 4.36B |
| Total current liabilities | 705.20M | 714.85M | 691.74M | 700.13M | 639.52M | 728.03M |
| Short-term debt | 77.69M | 82.92M | 84.33M | 85.77M | 93.85M | 90.14M |
| Long-term debt | 1.48B | 1.38B | 1.32B | 1.23B | 1.33B | 1.31B |
| Total liabilities | 3,096,523,000.00 | 3,029,429,000.00 | 2,936,624,000.00 | 2,881,467,000.00 | 2,916,024,000.00 | 2,971,605,000.00 |
| Total equity | 1.97B | 1.42B | 1.36B | 1.29B | 1.43B | 1.38B |
| Retained earnings | 3.72B | 3.23B | 3.38B | 3.48B | 3.62B | 3.82B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 114.16M | 89.96M | 266.90M | 567.17M | 603.14M | 930.44M | 992.49M | 710.43M |
| Depreciation & amortization | 29.25M | 24.21M | 27.62M | 31.98M | 39.23M | 54.30M | 69.84M | 79.28M |
| Free cash flow | 102.18M | 53.38M | 224.87M | 511.25M | 498.95M | 814.82M | 923.14M | 659.20M |
| Dividends paid | -21.02M | -2.99M | 0 | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -63.13M | -148.72M | -173.89M | -1.02B | -11.48M | -192.11M | -560.69M | -586.57M |
| Ending cash balance | 127.53M | 112.05M | 139.27M | 216.93M | 194.89M | 153.10M | 183.68M | 133.91M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -67.24M | 285.80M | 239.34M | 252.53M | -80.93M | 351.70M |
| Depreciation & amortization | 18.54M | 19.47M | 20.33M | 20.95M | 20.24M | 20.05M |
| Free cash flow | -82.61M | 269.23M | 226.16M | 246.42M | -98.93M | 330.97M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -64.18M | -134.07M | -208.16M | -180.17M | -2.46M | -256.94M |
| Ending cash balance | 169.74M | 204.18M | 157.52M | 133.91M | 134.35M | 173.83M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -41.18 | 84.69 | 148.09 | 476.31 | 129.84 | 69.77 | 57.76 | -5.19 |
| ROA %i | -13.67 | 19.79 | 33.69 | 54.49 | 17.87 | 17.33 | 20.09 | -1.81 |
| ROIC %i | -24.11 | 29.69 | 53.39 | 90.26 | 29.23 | 27.28 | 29.59 | -0.40 |
| 5-year avg ROE %i | -17.80 | -0.15 | 35.08 | 133.06 | 159.55 | 181.74 | 176.35 | 145.70 |
| EBIT margin %i | 6.08 | 10.40 | 15.42 | 29.63 | 24.04 | 26.19 | 24.86 | 3.99 |
| FCF / sales %i | 9.39 | 4.34 | 16.22 | 22.10 | 14.04 | 20.56 | 22.50 | 16.31 |
| Current ratioi | 2.06 | 1.65 | 1.69 | 1.72 | 1.60 | 1.30 | 1.18 | 1.27 |
| Quick ratioi | 1.26 | 0.88 | 1.02 | 1.11 | 0.81 | 0.69 | 0.63 | 0.66 |
| Debt / assetsi | 25.59 | 53.29 | 33.38 | 62.36 | 57.64 | 42.99 | 35.35 | 38.66 |
| LT debt / equityi | 79.84 | 261.66 | 112.31 | 6,537.62 | 307.26 | 131.42 | 88.94 | 118.15 |
| Interest coveragei | 69.23 | 14.82 | 31.70 | 31.67 | 6.28 | 6.43 | 9.33 | 1.83 |
| Revenue CAGR (3Y) %i | -0.07 | 5.90 | 10.63 | 28.58 | 42.42 | 41.93 | 21.04 | 4.36 |
| Net income CAGR (3Y) %i | -- | -- | 212.64 | 143.22 | 65.34 | 36.32 | 9.40 | -- |
| FCF CAGR (3Y) %i | -- | 44.86 | 38.23 | 71.03 | 110.65 | 53.60 | 21.77 | 9.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 53.70 | 15.39 | 11.82 | -5.19 | -6.11 | 42.30 |
| ROA %i | 19.42 | 5.16 | 4.05 | -1.81 | -2.21 | 13.48 |
| ROIC %i | 27.65 | 9.21 | 7.69 | -0.40 | -1.53 | 20.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.95 | 6.56 | 5.19 | 3.99 | 3.30 | 20.78 |
| FCF / sales %i | 21.55 | 18.58 | 17.59 | 16.31 | 15.97 | 17.38 |
| Current ratioi | 1.52 | 1.54 | 1.40 | 1.27 | 1.67 | 1.49 |
| Quick ratioi | 0.90 | 0.90 | 0.74 | 0.66 | 0.94 | 0.86 |
| Debt / assetsi | 36.77 | 39.85 | 39.67 | 38.66 | 39.73 | 38.78 |
| LT debt / equityi | 90.63 | 118.97 | 118.96 | 118.15 | 114.31 | 115.48 |
| Interest coveragei | 10.08 | 2.86 | 2.34 | 1.83 | 1.55 | 10.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Crocs Brand is the largest reported line at 84.82% of revenue, across 2 reported segments.
- The next-largest line, HEYDUDE Brand, is a distant second at 15.18% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Crocs Brand84.82%
HEYDUDE Brand15.18%
Quote time 2026-10-08 07:08:04 · For reference only, not investment advice and not tailored to your situation.